HEALTH● LOWAug 20 · Aug 20, 2026, 6:16 PM
mRNA Vaccine May Extend High-Risk Melanoma Remission
Human Progress
“An experimental mRNA vaccine allowed people with high-risk melanoma to live longer, cancer-free, the pharmaceutical companies Moderna and Merck announced Wednesday. For decades, cancer vaccines have been one of the most tantalizing ideas in cancer treatment — offering the hope of harnessing a person’s own immune system to attack tumors… In the late-stage trial of […] The post mRNA Vaccine May Extend High-Risk Melanoma Remission appeared first on Human Progress.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH37m agoFrance reports first human case of livestock virus ShamondaIrish Times WorldHEALTH42m agoHealth authorities race to investigate first human death linked to rare cattle virusThe TelegraphHEALTH46m agoFirst human infected with livestock disease shamondavirus, French patient deceasedNOS BuitenlandHEALTH50m agoHuman Shamonda Virus: Reported Case Has No Health Risk, Says FranceChannels TV